Erste Asset Management GmbH Buys 27,237 Shares of Agilent Technologies, Inc. $A

Erste Asset Management GmbH grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 22.8% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 146,509 shares of the medical research company’s stock after purchasing an additional 27,237 shares during the period. Erste Asset Management GmbH’s holdings in Agilent Technologies were worth $19,986,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Massachusetts Financial Services Co. MA lifted its position in Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after buying an additional 1,713,216 shares in the last quarter. Wellington Management Group LLP lifted its position in Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after buying an additional 433,342 shares in the last quarter. Geode Capital Management LLC lifted its position in Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after buying an additional 25,139 shares in the last quarter. Generation Investment Management LLP lifted its position in Agilent Technologies by 10.1% during the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after buying an additional 582,093 shares in the last quarter. Finally, Norges Bank bought a new stake in Agilent Technologies during the 4th quarter worth about $549,158,000.

Agilent Technologies Stock Performance

NYSE A opened at $132.88 on Tuesday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $37.53 billion, a price-to-earnings ratio of 26.68, a P/E/G ratio of 2.41 and a beta of 1.26. The firm’s 50 day simple moving average is $118.73 and its 200 day simple moving average is $128.16. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter last year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.99 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Analyst Upgrades and Downgrades

A has been the topic of a number of research analyst reports. Morgan Stanley dropped their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Royal Bank Of Canada started coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price target on the stock. UBS Group decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $161.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.